131 related articles for article (PubMed ID: 36124708)
21. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
22. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients.
Oue N; Sentani K; Noguchi T; Ohara S; Sakamoto N; Hayashi T; Anami K; Motoshita J; Ito M; Tanaka S; Yoshida K; Yasui W
Int J Cancer; 2009 Nov; 125(10):2383-92. PubMed ID: 19670418
[TBL] [Abstract][Full Text] [Related]
23. The Transition from Gastric Intestinal Metaplasia to Gastric Cancer Involves
Gingold-Belfer R; Kessler-Icekson G; Morgenstern S; Rath-Wolfson L; Zemel R; Boltin D; Levi Z; Herman-Edelstein M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069715
[TBL] [Abstract][Full Text] [Related]
24. From part to whole, operative link on to endoscopic grading of gastric intestinal metaplasia, pathology to endoscopy: gastric intestinal metaplasia graded by endoscopy.
Wei N; Zhou M; Lei S; Yang L; Duan Z; Zhang Y; Zhong Z; Liu Y; Shi R
Future Oncol; 2022 Jun; 18(19):2445-2454. PubMed ID: 35574611
[No Abstract] [Full Text] [Related]
25. Gastric intestinal metaplasia assessment between linked color imaging based on endoscopy and pathology.
Zhang G; Zheng J; Zheng L; Yu S; Jiang C; Lin W; Li D; Qu L; Wang W
Scand J Gastroenterol; 2021 Jan; 56(1):103-110. PubMed ID: 33232631
[TBL] [Abstract][Full Text] [Related]
26. Study on the Mechanism of Olfactomedin 4-shRNA Plasmid Chitosan Magnetic Nanoparticles in Intestinal Metaplasia of Chronic Atrophic Gastritis.
Li H; Li J; Li P; Zhang W; Yang W; Xu Y; Kang J; Zhang J; Wu Y; Pan H; Guo S
J Nanosci Nanotechnol; 2020 Dec; 20(12):7324-7332. PubMed ID: 32711597
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of gastric cancer precursors in gastroscopy-screened adults by family history of gastric cancer and of cancers other than gastric.
Wu R; Yang C; Ji L; Fan ZN; Tao YW; Zhan Q
BMC Cancer; 2020 Nov; 20(1):1110. PubMed ID: 33198658
[TBL] [Abstract][Full Text] [Related]
28. Race/Ethnicity and Birthplace as Risk Factors for Gastric Intestinal Metaplasia in a Multiethnic United States Population.
Tan MC; Jamali T; Nguyen TH; Galvan A; Sealock RJ; Khan A; Zarrin-Khameh N; Holloman A; Kampagianni O; Ticas DH; Liu Y; El-Serag HB; Thrift AP
Am J Gastroenterol; 2022 Feb; 117(2):280-287. PubMed ID: 34908535
[TBL] [Abstract][Full Text] [Related]
29. Subtyping intestinal metaplasia in patients with chronic atrophic gastritis: an interobserver variability study.
Lerch JM; Pai RK; Brown I; Gill AJ; Jain D; Kővári B; Kushima R; Sheahan K; Slavik T; Srivastava A; Lauwers GY; Langner C
Pathology; 2022 Apr; 54(3):262-268. PubMed ID: 35221041
[TBL] [Abstract][Full Text] [Related]
30. Identification of AQP3 and CD24 as biomarkers for carcinogenesis of gastric intestinal metaplasia.
Zhao H; Wen J; Dong X; He R; Gao C; Zhang W; Zhang Z; Shen L
Oncotarget; 2017 Sep; 8(38):63382-63391. PubMed ID: 28968998
[TBL] [Abstract][Full Text] [Related]
31. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.
Watari J; Das KK; Amenta PS; Tanabe H; Tanaka A; Geng X; Lin JJ; Kohgo Y; Das KM
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):409-17. PubMed ID: 18321787
[TBL] [Abstract][Full Text] [Related]
32. Gastric Cancer Screening in First-Degree Relatives: A Pilot Study in a Diverse Integrated Healthcare System.
Dong EY; Giap AQ; Lustigova E; Wu BU
Clin Transl Gastroenterol; 2022 Nov; 13(11):e00531. PubMed ID: 36113027
[TBL] [Abstract][Full Text] [Related]
33. Differences in genetic instability and cellular phenotype among Barrett's, cardiac, and gastric intestinal metaplasia in a Japanese population with Helicobacter pylori.
Watari J; Moriichi K; Tanabe H; Sato R; Fujiya M; Miwa H; Das KM; Kohgo Y
Histopathology; 2009 Sep; 55(3):261-9. PubMed ID: 19723140
[TBL] [Abstract][Full Text] [Related]
34. Intelligent diagnosis of gastric intestinal metaplasia based on convolutional neural network and limited number of endoscopic images.
Yan T; Wong PK; Choi IC; Vong CM; Yu HH
Comput Biol Med; 2020 Nov; 126():104026. PubMed ID: 33059237
[TBL] [Abstract][Full Text] [Related]
35. Acetic Acid Enhanced Narrow Band Imaging for the Diagnosis of Gastric Intestinal Metaplasia.
Sha J; Wang P; Zhu B; Zhu M; Li X; Gao F
PLoS One; 2017; 12(1):e0170957. PubMed ID: 28135297
[TBL] [Abstract][Full Text] [Related]
36. Ethnicity Is an Important Consideration in Screening for Gastric Intestinal Metaplasia.
Kligman E; Ali H; Chen E; Peng F; Szafron D; Staggers K; Tan MC; Patel K; Othman MO
Dig Dis Sci; 2022 Sep; 67(9):4509-4517. PubMed ID: 34981309
[TBL] [Abstract][Full Text] [Related]
37. Risk of Gastric Cancer Among Patients With Intestinal Metaplasia of the Stomach in a US Integrated Health Care System.
Reddy KM; Chang JI; Shi JM; Wu BU
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1420-5. PubMed ID: 27317852
[TBL] [Abstract][Full Text] [Related]
38. Preferential expression of cyclooxygenase-2 in colonic-phenotype of gastric intestinal metaplasia: association with helicobacter pylori and gastric carcinoma.
Sun JH; Das KK; Amenta PS; Yokota K; Watari J; Sato T; Kohgo Y; Das KM
J Clin Gastroenterol; 2006 Feb; 40(2):122-8. PubMed ID: 16394872
[TBL] [Abstract][Full Text] [Related]
39. Factors affecting survival in operated gastric cancer.
Sakin A; Sahin S; Sakin A; Aldemir MN; Sakoglu N; Bayram I; Kotan MC
Surg Oncol; 2023 Feb; 46():101887. PubMed ID: 36455334
[TBL] [Abstract][Full Text] [Related]
40. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
